Health
20 Oct 2026
FDA clears Sequel Med Tech’s Twiist system for type 2 diabetes
The FDA has cleared Sequel Med Tech’s Twiist automated insulin delivery system for adults with insulin‑treated type 02 diabetes, after a multicentre trial showed better glycaemic control and fewer insulin units needed.
Read more